The largest database of trusted experimental protocols

Anti cd44 bv650 clone im7

Manufactured by BioLegend

Anti-CD44-BV650 (clone IM7) is a fluorochrome-conjugated monoclonal antibody that binds to the CD44 antigen. CD44 is a cell surface glycoprotein involved in cell-cell interactions, cell adhesion, and migration. This antibody can be used for the identification and analysis of CD44-expressing cells in flow cytometry applications.

Automatically generated - may contain errors

3 protocols using anti cd44 bv650 clone im7

1

Comprehensive Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used in a surface panel cocktail for the Bl-Eng2 peptide experiments: anti-CD45–Alexa Fluor 488 (clone 30-F11; Biolegend, catalog no. 103122), anti-major histocompatibility complex (MHC) class II tetramer–phycoerythrin (PE), anti-CD4–BUV395 (clone GK1.1; BD, catalog no. 563790), anti-CD8–peridinin chlorophyll protein (PerCP)-Cy5.5 (clone 53-6.7; Biolegend, catalog no. 100734), anti-CD44–BV650 (clone IM7; Biolegend, catalog no. 1033049), anti-CD11b–allophycocyanin (APC) (clone M1/70; Biolegend, catalog no. 101212), anti-CD11c–APC (clone N418; Biolegend, catalog no. 117310), anti-NK1.1–APC (clone PK136; Biolegend, catalog no. 108710), and anti-B220–APC (clone RA3-62B; Biolegend, catalog no. 103212).
+ Open protocol
+ Expand
2

Multiparametric Flow Cytometry Analysis of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were washed twice with staining buffer (PBS containing 2% fetal bovine serum [FBS]) and stained with fluorescence-conjugated antibodies against surface markers wherever appropriate, including anti-Thy1.1 BV510 clone OX-7 (BioLegend), anti-CD4 PerCP-Cy5.5 clone RM4-5 (eBioscience), anti-CD8α PE-Cy7 clone 53-6.7 (eBioscience), anti-CD44 BV650 clone IM7 (BioLegend), anti-CD69 PE clone H1.2F3 (eBioscience), anti-CD103 BV421 clone 2E7 (BioLegend), anti-CD62L BUV737 clone MEL-14 (BD Biosciences), anti-KLRG-1 BUV395 clone 2F1 (BD Biosciences), anti-CD11c BB515 clone N418 (BD Biosciences), anti-CD11b BV711 clone M1/70 (BD Biosciences), anti-MHC-II, anti-CD86, anti-CD103, and anti-F4/80 for 30 min. For intracellular IFN-γ staining, cells were fixed and permeabilized (Foxp3/Transcription Factor Fixation/Permeabilization Concentrate and Diluent, eBioscience) after surface staining and then stained intracellularly with anti-IFN-γ-APC (BD Biosciences). Cells were analyzed with a fluorescence-activated cell sorting (FACS) LSRFortessa flow cytometer (BD Biosciences).
+ Open protocol
+ Expand
3

Mapping T-cell Epitopes in NSs Antigen

Check if the same lab product or an alternative is used in the 5 most similar protocols
T-cell epitopes were mapped within NSs antigen. IFN-γ ELISpot assays were performed with splenocytes from vaccinated mice by stimulation with a single peptide (15-mer; total 41 peptides). Peptides with high numbers of IFN-γ spots were identified, and the epitope sequence corresponding to high-affinity binding to mouse MHC class Ι, H-2Ld was identified using NetMHC 4.0 (Technical University of Denmark). The epitope peptide YPYLMAHYL was used to synthesize the H-2Ld dextramer (H-2Ld NSs247–255 dextramer, Immunedex). Splenocytes of vaccinated mice were stained with PE–conjugated H-2Ld NSs247–255 dextramer at 4 °C for 20 min, followed by washing with FACS buffer (PBS containing 1% FBS and 0.05% sodium azide). For live/dead and surface staining, the following reagent and antibodies were used: Live/Dead Fixable Red Dead Cell stain kit (Invitrogen), anti-CD19–PE-CF594 (clone 1D3, BD Biosciences, 562291, 1:100), anti-CD8–BV510 (clone 53-6.7, BD Biosciences, 560776, 1:100), anti-CD62L–BV605 (clone MEL-14, BD Biosciences, 563252, 1:50), anti-CD44–BV650 (clone IM7, BioLegend, 103049, 1:50), and anti-CD3–Alexa Fluor 700 (clone 500A2, eBioscience, 56-0033-82, 1:100).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!